Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer
Article in BMC Medicine (April 2024)
The most recent citing publications are shown below. View all 468 publications that cite this research output on Dimensions.
Article in BMC Medicine (April 2024)
Article in Cancer Cell International (April 2024)
Article in Journal of Advanced Research (April 2024)